Sibold William John sold MDGL
September 11, 2026 · Form 4 insider transaction
Sibold William John sold 160 shares of Madrigal Pharmaceuticals, Inc. at $537.62 per share, a transaction worth $86.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
160
Price
$537.62
Total value
$86.0K
InsiderSibold William John
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 11, 2026
Filing dateSeptember 11, 2026
Shares owned after202,423
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These sales were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 5, 2026.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $537.235 to $538.00, inclusive.